GOZLEM
13th Technology Awards by TUBITAK, TTGV and TUSIAD
About RS Research
This author has not written his bio yet.
But we are proud to say that RS Research contributed 66 entries already.
Entries by RS Research
DUNYA
Prof. Dr. Rana Sanyal was named Promising Female Entrepreneur
DAILY SABAH
Turkey’s new locally made cancer drug counts down to launch
HURRIYET
Developing cancer drug in Turkey
HURSES
Prof. Dr. Rana Sanyal was named Promising Female Entrepreneur 2019 by Garanti BBVA, Ekonomist and KAGİDER
ISTANBUL TICARET
To the point local drug against cancer
CUMHURIYET
Garanti grants 5 billion to entrepreneurship
SOZCU
Women Entrepreneurs Awards
HURRIYET
Start-ups of 2018
HABERTURK
RS Research started 2018 with 900 thousand Euro investment
RS Research is a clinically-validated biotech company developing targeted oncology therapies using Sagitta® drug-delivery platforms, disrupting the efficacy-toxicity trade-off.
